Pharmaceutical Regulatory Affairs In Russia, Eurasian Union And The CIS 2-Day Online Training Course: September 30, 2026 And Oct 1, 2026

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Russia, Eurasian Union and the CIS (September 30, 2026 and Oct 1, 2026)" training has been added to ResearchAndMarkets's offering.

The pharmaceutical markets in Russia, the Eurasian Union and the CIS are of growing commercial importance and companies looking to take advantage of the opportunities available need to be fully up to date with the evolving regulatory landscape for human pharmaceuticals, including the potential for market access offered by the latest legislation.

This interactive course will guide you through national procedures as well as exploring the implications of and updates on the Eurasian Union regulation.

The focus of the programme is to offer practical advice in developing your regulatory strategy for product approval in these countries and you will get the full benefit of our trainer's experience and expertise in the region.

CPD Hours: 12

Who should attend?

This course will be of particular interest to all those who need to learn about successful marketing authorisation applications and regulatory compliance in this region. It will also be useful either as an introductory or refresher course.

Please note this course will only cover human pharmaceuticals not animal (veterinary) pharmaceuticals.

Key Topics Covered:

• Day 1
  • CIS - regional regulatory overview
  • Common regional requirements in CIS
  • Eurasian economic area
  • Eurasian Regulations for Medicines
• Day 2
  • Registration of Medicine in Russia
  • National Regulatory Procedures in Russia
  • Registration in other EAEU countries
  • Registration in other CIS countries
  • Workshop - CIS Regional Regulatory Strategy

Speaker

Anna Harrington-Morozova is a regulatory, drug development and external relations professional with over 20 years' experience gained working in a Regulatory Authority, academia and industry. Anna graduated in Russia as a pharmacist. After working in the Russian Ministry of Health and the Clinical Pharmacology Department of Moscow Medical University, she held regulatory and external relation positions in the pharmaceutical industry and CROs in Russia and the UK, including senior regulatory affairs posts in GSK,EISAI, ICON and PRA.

Anna currently acts a a Scientific and Reguatory director at Regem Consulting Ltd - a consultancy which focuses on drug development, global regulatory advice, professional trainings and flexible resourcing solutions for the pharmaceutical, biotech and medical device industries in emerging markets.

For more information about this training visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN11052026004107003653ID1111095539